Atlas Trials

Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects

Clinical trial NCT02546310 · COMPLETED

Trial details

NCT number
NCT02546310
Sponsor
Nxera Pharma UK Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2015-10-01
Primary completion
2017-02-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.